中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2014年
12期
1147-1149
,共3页
章考飞%薛美玲%凌艺兰%汪峰
章攷飛%薛美玲%凌藝蘭%汪峰
장고비%설미령%릉예란%왕봉
临床药师%药学监护%化疗%小细胞肺癌%药品不良反应
臨床藥師%藥學鑑護%化療%小細胞肺癌%藥品不良反應
림상약사%약학감호%화료%소세포폐암%약품불량반응
Clinical pharmacist%Pharmaceutical care%Chemotherapy%Small cell lung cancer%Adverse drug reaction
目的：探讨临床药师对化疗患者进行药学监护的方法，促进合理用药。方法：针对1例小细胞肺癌化疗患者，临床药师分析化疗方案，提供药学监护。结果：该患者的化疗方案为伊立替康联合顺铂，药品不良反应的发生率较高，临床药师及时地制订和调整化疗方案，合理地应用药物预防方案，避免了更严重不良反应的发生；对化疗过程中出现的骨髓抑制、严重腹泻、肠梗阻等问题，结合患者病情，依据相关治疗指南及临床药学知识，与临床医师共同讨论和实施升高白细胞、止泻及胃肠减压等用药方案，根据疗效及时调整用药，使肿瘤患者顺利完成化疗周期。结论：临床药师应深入临床，参与患者治疗全过程，密切配合医师监测患者各项临床指标，协助制定治疗方案，并对患者进行用药指导，以促进临床安全、有效用药。
目的：探討臨床藥師對化療患者進行藥學鑑護的方法，促進閤理用藥。方法：針對1例小細胞肺癌化療患者，臨床藥師分析化療方案，提供藥學鑑護。結果：該患者的化療方案為伊立替康聯閤順鉑，藥品不良反應的髮生率較高，臨床藥師及時地製訂和調整化療方案，閤理地應用藥物預防方案，避免瞭更嚴重不良反應的髮生；對化療過程中齣現的骨髓抑製、嚴重腹瀉、腸梗阻等問題，結閤患者病情，依據相關治療指南及臨床藥學知識，與臨床醫師共同討論和實施升高白細胞、止瀉及胃腸減壓等用藥方案，根據療效及時調整用藥，使腫瘤患者順利完成化療週期。結論：臨床藥師應深入臨床，參與患者治療全過程，密切配閤醫師鑑測患者各項臨床指標，協助製定治療方案，併對患者進行用藥指導，以促進臨床安全、有效用藥。
목적：탐토림상약사대화료환자진행약학감호적방법，촉진합리용약。방법：침대1례소세포폐암화료환자，림상약사분석화료방안，제공약학감호。결과：해환자적화료방안위이립체강연합순박，약품불량반응적발생솔교고，림상약사급시지제정화조정화료방안，합리지응용약물예방방안，피면료경엄중불량반응적발생；대화료과정중출현적골수억제、엄중복사、장경조등문제，결합환자병정，의거상관치료지남급림상약학지식，여림상의사공동토론화실시승고백세포、지사급위장감압등용약방안，근거료효급시조정용약，사종류환자순리완성화료주기。결론：림상약사응심입림상，삼여환자치료전과정，밀절배합의사감측환자각항림상지표，협조제정치료방안，병대환자진행용약지도，이촉진림상안전、유효용약。
OBJECTIVE: To explore the approaches for clinical pharmacist to carry out pharmaceutical care for patient receiving chemotherapy so as to promote rational use of drug. METHODS: Clinical pharmacist analyzed the chemotherapy regimen and provided pharmaceutical care for one patient with small cell lung cancer( SCLC) . RESULTS:The chemotherapy regimen consisted of irinotecan and cisplatin; due to the high incidence of adverse drug reactions, clinical pharmacist timely formulated and adjusted the chemotherapy, reasonably applied the chemoprophylaxis programs, which helped avoid the occurrence of more serious adverse reactions; clinical pharmacist discussed the problems noted during chemotherapy such as bone marrow suppression, severe diarrhea, intestinal obstruction etc with clinicians based on patients? condition taking the related treatment guideline and clinical pharmaceutical knowledge as references, carried out a series of schemes to increase white blood cell count, check diarrhea and achieve gastrointestinal decompression, adjusted drug use based on efficacy, which facilitated cancer patients? smooth completion of periodical chemotherapy. CONCLUSIONS:Clinical pharmacists‘involvement in patients’ clinical treatment by closely cooperate with physicians to monitor patients?clinical indicators, make therapeutic regimens, provide medication guidance among patients contributed to patients? safe and effective medication.
